Combination of tivozanib, an oral inhibitor of VEGFR, with weekly paclitaxel for metastatic breast cancer: Preliminary results of an ongoing phase 1 study Meeting Abstract


Authors: Mayer, E. L.; Scheulen, M.; Beckman, J.; Richly, H.; Poli, A.; Bhargava, P.; Duarte, A.; Cotreau, M.; Al-Adhami, M.; Dickler, M.
Abstract Title: Combination of tivozanib, an oral inhibitor of VEGFR, with weekly paclitaxel for metastatic breast cancer: Preliminary results of an ongoing phase 1 study
Meeting Title: 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 70
Issue: 24 Suppl.
Meeting Dates: 2010 Dec 9-12
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2010-12-15
Language: English
ACCESSION: WOS:000209695801153
DOI: 10.1158/0008-5472.sabcs10-p2-16-10
PROVIDER: wos
Notes: Meeting Abstract: P2-16-10 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Maura N Dickler
    263 Dickler